FDA Investigator Andrew R Wasko
Andrew R Wasko has inspections in 1 countries as of 15 Sep 2023. Andrew R Wasko has collaborated with a combined 1077 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Andrea A Branche,
Audrey J Yarbrough,
Barbar J Breithaupt,
Barbara Janine Breithaupt,
Byungja E Marciante,
Carl A Anderson,
Charles M Kerns, BLT DO,
Charles R Bonapace, PhD,
Connie P Rezendes,
Courtney N Long,
Craig T Rybus,
Ct Viswanathan, PhD,
Da Lin Yao, MD, PhD,
Darren S Morgan,
David K Glasgow,
David L Chon,
Donald B Mckechnie,
Douglas Fiorentino Lcdr,
Douglas Florentino,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Elizabeth Ll Edwards,
Erin M Mcdowell,
Gilbert J Heidenblut,
Grace P Santos,
Hector J Colon Torres,
Heika R Bounds,
Heika R Tait,
Hugh M Mcclure, II,
Hugh M Mecture, III,
Jacqueline A O'shaughnessy, PhD,
Jane M Kreis,
Julian C Hanson,
Kathryn A Krentz,
Kathryn Suttling,
Linda S Leja,
Lori J Silverstein,
LT Melanie M Mayor, USPHS,
Marcia A Worley,
Maria Pkelly Doggett, MBA,
Matthew B Casale,
Michael F Skelly, PhD,
Phillip M Pontikos,
Robert J Martin,
Rosanna M Goodrich,
Sherry L Secrist, BLT DO,
Stephen J Kilker,
Sunitha K Rajaram, PhD,
Susanne M Richardson, MSc RAC ELS,
Susanne Mrichardsonmsc Rac,
Victoria M Daddeo,
Yvette Mlacour Davis
Andrew R Wasko's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2023 | FDA 483 | Altasciences Preclinical Seattle, LLC - Form 483, 2023-07-14 |
May, 2023 | FDA 483 | NAMSA, LLC - Form 483, 2023-05-12 |
September, 2023 | FDA 483 | University of Texas Medical Branch - Form 483, 2023-12-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more